Search Results 1361-1370 of 20120 for Hepatitis C

1. ARTEMIS - A Research Study To Look At How Ziltivekimab Works Compared To Placebo In People With A Heart Attack - Mayo Clinic

   -Known (acute or chronic) hepatitis B or hepatitis C -History or evidence of untreated latent tuberculosis (TB) such as (but not limited to): a) History of ...

2. A Study of Donated Alloantigen Reactive Regulatory T Cells for Reducing or Discontinuing Immune System Suppression in Liver Transplant Patients - Mayo Clinic

   Transplant for liver disease secondary to hepatitis C or autoimmune disease (e.g. autoimmune hepatitis, primary sclerosing cholangitis, or primary biliary ...

3. Publications - Charles G. Graham, M.D. - Mayo Clinic

   Bokhari MR, Graham C, Mohseni M. Eagle Syndrome. StatPearls Treasure Island (FL) StatPearls Publishing 2025 Jan View PubMed; Mohseni M, Mabrouk A, Li D, ...

4. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Active hepatitis B or C with uncontrolled disease;. Note: a detailed assessment of Hepatitis B/C medical history and risk factors must be done at screening ...

5. Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) - Mayo Clinic

   Known positive for Hepatitis B surfaces antigen, or Hepatitis C antibody, or who have been tested positive for HIV; Patients with any concurrent malignancy ...

6. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

   Known infection or chronic infection with hepatitis B virus (hepatitis B surface antigen. [HBsAg] positive) or hepatitis C virus (HCV) (anti-HCV positive).

7. Transplant Medicine Physicians - Medical Professionals - Mayo Clinic

   Peter C. Rhee, D.O., M.S.. Rochester, MN. Area of ... hepatitis, Alcoholic hepatitis, Hepatopulmonary syndrome, Liver disease, Liver cancer, Hepatic ...

8. Pilot and Feasibility Program - Mayo Clinic Research

   Pilot and Feasibility Program. The Center for Cell Signaling in Gastroenterology (C-SiG) recognizes that developing the next generation of investigators is ...

9. PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies - Mayo Clinic

   ... C or D. History or evidence of a clinically unstable/uncontrolled disorder ... Positive test for human immunodeficiency virus -I or -II antibodies, hepatitis B ...

10. Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary - Mayo Clinic

    Known prior/current history of hepatitis related to hepatitis B or hepatitis C. Uncontrolled intercurrent illness including, but not limited to the following ...